Skip to main content

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Veeva Systems (VEEV), Zymeworks (ZYME) and Senseonics Holdings (SENS)

Tipranks - Wed Mar 4, 6:30AM CST

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Veeva Systems (VEEVResearch Report), Zymeworks (ZYMEResearch Report) and Senseonics Holdings (SENSResearch Report).

Claim 70% Off TipRanks Premium

Veeva Systems (VEEV)

In a report released today, Steven Valiquette from Mizuho Securities maintained a Buy rating on Veeva Systems, with a price target of $295.00. The company’s shares closed last Monday at $181.45, close to its 52-week low of $170.25.

According to TipRanks.com, Valiquette is a 2-star analyst with an average return of 0.3% and a 52.7% success rate. Valiquette covers the Healthcare sector, focusing on stocks such as Solventum Corporation, Envista Holdings, and Cardinal Health. ;'>

The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Veeva Systems with a $256.10 average price target, a 42.2% upside from current levels. In a report issued on February 17, TipRanks – xAI also upgraded the stock to Buy with a $192.00 price target.

See today’s best-performing stocks on TipRanks >>

Zymeworks (ZYME)

In a report released today, Stephen Willey from Stifel Nicolaus maintained a Buy rating on Zymeworks, with a price target of $47.00. The company’s shares closed last Monday at $23.31.

According to TipRanks.com, Willey is a 4-star analyst with an average return of 7.6% and a 42.4% success rate. Willey covers the Healthcare sector, focusing on stocks such as Bicara Therapeutics Inc., Abeona Therapeutics, and AbCellera Biologics. ;'>

Currently, the analyst consensus on Zymeworks is a Strong Buy with an average price target of $35.80, implying a 58.8% upside from current levels. In a report issued on February 20, Citi also maintained a Buy rating on the stock with a $35.00 price target.

Senseonics Holdings (SENS)

Stifel Nicolaus analyst Jonathan Block reiterated a Hold rating on Senseonics Holdings today and set a price target of $9.00. The company’s shares closed last Monday at $8.33.

According to TipRanks.com, Block is a 4-star analyst with an average return of 6.8% and a 51.6% success rate. Block covers the Healthcare sector, focusing on stocks such as Inspire Medical Systems, Elanco Animal Health, and Tandem Diabetes Care. ;'>

The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Senseonics Holdings with a $18.70 average price target, representing a 134.6% upside. In a report released today, TipRanks – Google also downgraded the stock to Hold with a $9.00 price target.

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.